ASP External Reports

December 2018 - The Detection and Reporting of Colistin Resistance (World Health Organization Global Antimicrobial Resistance Surveillance System). 

October 2018 - Innovation in AMR: patent trends for novel diagnostics (The Longitude Prize)

July 2018 2018 BASHH UK National Guidelines for the Management of Infection with Mycoplasma genitalium (British Association for Sexual Health and HIV)

January 2018 - Accelerating Diagnostics Use to Prevent AMR (FIND)

September 2017 - Medical devices: Capabilities and challenges of technologies to enable rapid diagnoses of infectious diseases (US Government Accountability Office)

September 2017 - Recommendations for Incentivizing the Development of Therapeutics, Diagnostics, and Vaccines to Combat Antibiotic-Resistance (US Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria)

May 2017 - Changing Diagnostic Paradigms for Microbiology (American Academy of Microbiology)

January 2017 - Unleashing the Power of Diagnostic Tests in the Fight Against Antibiotic Resistance (The George Washington University Milken Institute School of Public Health Antibiotic Resistance Action Center and AdvaMedDx)

November 2017 - A Multiplex Multi-Analyte Diagnostic Platform (World Health Organization, FIND, and Medicins Sans Frontieres)

July 2017 - Multiplex Array White Paper: Clinical Utility of Multiplex Tests for Respiratory and Gastrointestinal Pathogens (American Society for Microbiology)

April 2017 - Improving the development and deployment of rapid diagnostic tests in LMICs: Workshop report (The Academy of Medical Sciences)

November 2016  - Diagnostic stewardship: A guide to implementation in antimicrobial resistance surveillance sites (World Health Organization)

October 2015 - Rapid Diagnostics: Stopping Unnecessary Use of Antibiotics (The Review on Antimicrobial Resistance)

OUR UNDERWRITERS

Grant support for ASP provided by


bioMérieux

Unrestricted financial support provided by

Bentson FoundationAccelerate DiagnosticsUnited Health Group

    SpeeDx
    Nabriva Therapeutics 
 
Become an underwriter»